News

November 2004 Issue

In the News: 11/04

Methotrexate: In Low Doses, No Harm To Bone Health Despite in vitro studies showing that methotrexate can bring on negative changes in bone mass, in low doses—from 7.5 to 20 milligrams a week—the popular arthritis drug poses no risk of osteoporosis. So concludes a recent Italian study that tested 731 female patients with rheumatoid arthritis who were divided on the basis of methotrexate use (non-users vs. patients who had taken the drug for at least six…

To continue reading this entire article you must be a paid subscriber.

Subscribe to Arthritis Advisor

Arthritis Advisor is the first magazine published by one one of the world's leading orthopaedic hospitals specifically for people with arthritis.

Already subscribe but haven't registered for all the benefits of the website? Click here.

Subscriber Log In

Forgot your password? Click Here.